Inclusion of targeted skin products in the pre-surgical treatment regimen of peripheral lymphedema & lipedema.
暂无分享,去创建一个
[1] P. Matts,et al. A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia. , 2019 .
[2] F. Boccardo,et al. A Single-Site Technique of Multiple Lymphatic–Venous Anastomoses for the Treatment of Peripheral Lymphedema: Long-Term Clinical Outcome , 2015, Journal of Reconstructive Microsurgery.
[3] J. M. D. de Godoy,et al. Lipedema: Is Aesthetic Cellulite an Aggravating Factor for Limb Perimeter? , 2013, Journal of cutaneous and aesthetic surgery.
[4] L. Kemény,et al. Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome – systematic review , 2012, Clinical obesity.
[5] G. Gethin,et al. Prevalence of lymphoedema and quality of life among patients attending a hospital‐based wound management and vascular clinic , 2012, International wound journal.
[6] C. Moffatt,et al. The challenges of managing complex lymphoedema/chronic oedema in the UK and Canada , 2012, International wound journal.
[7] R. Neville,et al. Current Dilemmas and Controversy , 2011 .
[8] M. Titheradge,et al. The role of transforming growth factor‐β1 and oxidative stress in podoconiosis pathogenesis , 2010, The British journal of dermatology.
[9] F. Boccardo,et al. Microsurgery for lymphedema: Clinical research and long‐term results , 2010, Microsurgery.
[10] K. Alitalo,et al. Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema. , 2010, The American journal of pathology.
[11] G. Woodruff,et al. Lymphatic lipid transport : sewer or subway ? , 2010 .
[12] P. Scherer,et al. Mechanisms of obesity and related pathologies: The macro‐ and microcirculation of adipose tissue , 2009, The FEBS journal.
[13] G. Davey,et al. Development and testing of a de novo clinical staging system for podoconiosis (endemic non‐filarial elephantiasis) , 2008, Tropical medicine & international health : TM & IH.
[14] P. Carmeliet,et al. Lymph makes you fat , 2005, Nature Genetics.
[15] N. Liu. Trafficking of hyaluronan in the interstitium and its possible implications. , 2004, Lymphology.
[16] H. R. Maurer,et al. Bromelain: biochemistry, pharmacology and medical use , 2001, Cellular and Molecular Life Sciences CMLS.
[17] J. Casley‐Smith. Benzo-pyrones in the treatment of lymphoedema. , 1999, International angiology : a journal of the International Union of Angiology.
[18] P. Novotny,et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. , 1999, The New England journal of medicine.
[19] L. Zhang,et al. Changes of tissue fluid hyaluronan (hyaluronic acid) in peripheral lymphedema. , 1998, Lymphology.
[20] A. Szuba,et al. Lymphedema: Anatomy, Physiology and Pathogenesis , 1997, Vascular medicine.
[21] R. G. Morgan,et al. Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. , 1993, The New England journal of medicine.